CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. United Therapeutics Corporation Transaction History

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. portfolio value:

$11.89M
portfolio value

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. quarter portfolio value change:

-11.14%
quarter

United Therapeutics Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.53% -4.62K shares -2.58M $209.38 56.78K
Q2 2022 share Increase +16.30% 8.60K shares 4.99M $235.64 61.40K
Q1 2022 share Increase +34.37% 13.50K shares 982K $179.41 52.80K
Q4 2021 share Increase +158.69% 24.10K shares 5.68M $215.18 39.29K
Q3 2021 share Increase 0.00% 15.19K shares 2.80M $184.58 15.19K
Q1 2021 share Decrease -100.00% -4.25K shares -646K $167.27 0
Q4 2020 share Increase 0.00% 4.25K shares 646K $151.79 4.25K
Q4 2019 share Decrease -100.00% -44.85K shares -3.57M $88.08 0
Q3 2019 share Decrease -35.06% -24.21K shares -1.81M $79.75 44.85K
Q2 2019 share Increase +261.65% 49.97K shares 3.15M $78.06 69.07K
Q1 2019 share Decrease -57.72% -26.07K shares -2.67M $117.37 19.1K
Q4 2018 share Decrease -18.16% -10.02K shares -2.13M $108.9 45.17K
Q3 2018 share Decrease -22.44% -15.97K shares -994K $127.88 55.2K
Q2 2018 share Increase +1.32% 925 shares 160K $113.15 71.17K
Q1 2018 share Decrease -12.86% -10.36K shares -4.03M $112.36 70.24K
Q4 2017 share Decrease -13.41% -12.48K shares 1.01M $147.95 80.61K
Q3 2017 share Increase +32.05% 22.59K shares 1.76M $117.19 93.09K
Q2 2017 share Increase 0.00% 70.5K shares 9.14M $129.73 70.5K
Q3 2016 share Decrease -100.00% -42.4K shares -4.49M $118.08 0
Q2 2016 share Increase +14.91% 5.5K shares 379K $105.92 42.4K
Q1 2016 share Decrease -2.38% -900 shares -1.80M $111.43 36.9K